Idiopathic Constipation
📧 Sign up to get email alerts when something new happens for Idiopathic Constipation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: This Study Aims to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties and Food Effect of IN-114199 in Healthy Participants [Phase 1]
Phase 1 clinical trial evaluating safety, tolerability, pharmacokinetics and pharmacodynamics, and food effect of IN-114199 in healthy parti…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Efficacy of a Dietary Intervention for the Treatment of Constipation in Institutionalized Older Adults. Medellín, 2023-2024. [NA]
This update reports the completion of a clinical trial evaluating the efficacy of a dietary intervention for treating constipation in instit…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Efficacy and Safety of Vibrant Capsule vs. Placebo for the Treatment of Chronic Idiopathic Constipation [NA]
This clinical trial update reports the efficacy and safety results of Vibrant Capsule versus placebo for chronic idiopathic constipation, wi…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Vibrant Capsule vs. Placebo for Patient Suffering From Constipation [NA]
The Vibrant Capsule trial for chronic idiopathic constipation has completed and results were posted on 2024-07-09, comparing Vibrant Capsule…
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Efficacy and Safety of Vibrant Capsule vs. Vibrant Placebo for the Treatment of Chronic Idiopathic Constipation (CIC) [Phase 4]
Phase 4 trial comparing Vibrant Capsule to placebo for chronic idiopathic constipation has completed and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: Effect of Abdominal Massage Versus Visceral Manipulation on Constipation [NA]
A clinical trial evaluating abdominal massage versus visceral manipulation for chronic idiopathic constipation; recruitment is ongoing at Ca…
-
FDA approval · 2023-06-12FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Linzess (linaclotide) submitted by Allergan.
-
FDA approval · 2023-03-23FDA Approved: LUBIPROSTONE — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approved the original application for lubiprostone from Zydus Pharmaceuticals USA Inc., establishing a generic version of Lubiprostone. …
-
FDA approval · 2022-01-18FDA Approved: LUBIPROSTONE — Original Application (Teva Pharmaceuticals, Inc.)
The FDA approved Teva's Lubiprostone generic under an original application (ANDA 209920). This marks approval of a generic version of lubipr…
-
FDA approval · 2021-04-12FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
FDA approved a supplemental application for Linzess (linaclotide) from Allergan, Inc., to update/expand its label.
-
CLINICAL_TRIALS trial_result · 2021-03-18Clinical Trial Update: Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation [Phase 3]
A Phase 3 trial evaluating clinical equivalence between two linaclotide products for chronic idiopathic constipation.
-
FDA approval · 2021-02-10FDA Approved: TRULANCE IMMEDIATE RELEASE — Supplemental Application (Salix Pharmaceuticals Inc.)
The FDA approved a supplemental application for Trulance Immediate Release (plecanatide) submitted by Salix Pharmaceuticals.
-
FDA approval · 2020-11-30FDA Approved: LUBIPROSTONE — Supplemental Application (Dr. Reddy's Laboratories Inc.)
The FDA approved a supplemental application for Lubiprostone submitted by Dr. Reddy's Laboratories, updating labeling under NDA 021908.
-
FDA approval · 2020-11-09FDA Approved: MOTEGRITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for MOTEGRITY (prucalopride) from Takeda Pharmaceuticals America, Inc., updating its labeling relate…
-
FDA approval · 2020-10-29FDA Approved: TRULANCE IMMEDIATE RELEASE — Supplemental Application (Salix Pharmaceuticals Inc.)
FDA approved a supplemental application to introduce an immediate-release formulation of Trulance (plecanatide) produced by Salix Pharmaceut…
-
FDA approval · 2020-09-22FDA Approved: LINZESS — Supplemental Application (Allergan, Inc.)
The FDA approved Allergan's supplemental application for Linzess (linaclotide), submitted by Allergan, Inc.
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults [Phase 3]
A Phase 3 clinical trial evaluating the safety and efficacy of BLI400 laxative in adults with constipation, including chronic idiopathic con…
-
CLINICAL_TRIALS trial_result · 2020-06-26Clinical Trial Update: An Open Label Study of Chronic Use of BLI400 Laxative in Constipated Adults [Phase 3]
Phase 3 open-label study of chronic use of the laxative BLI400 in adults with constipation showed completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2020-06-25Clinical Trial Update: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults [Phase 3]
Phase 3 trial evaluating safety and efficacy of BLI400 laxative in adults with chronic idiopathic constipation completed.
-
CLINICAL_TRIALS trial_result · 2020-01-14Clinical Trial Update: Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo [Phase 3]
Phase 3 trial evaluating bioequivalence of sprinkle and capsule lubiprostone formulations versus placebo in chronic idiopathic constipation;…
-
CLINICAL_TRIALS trial_result · 2020-01-02Clinical Trial Update: SP-304 Dose Ranging Study in Patients With Chronic Idiopathic Constipation [Phase 2]
Phase 2 dose-ranging study of SP-304 in chronic idiopathic constipation has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: Pharmacodynamic, Pharmacokinetic, and Tolerability Study of a Liquid Form of Lubiprostone in Adult Subjects With Chronic Idiopathic Constipation [Phase 3]
Phase 3 pharmacodynamic, pharmacokinetic, and tolerability study of a liquid form of lubiprostone in adults with chronic idiopathic constipa…
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation [Phase 2]
Phase 2 trial assessing plecanatide for efficacy and safety in adolescents (12 to <18) with chronic idiopathic constipation has completed wi…
-
CLINICAL_TRIALS research · 2019-08-22Clinical Trial Update: An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation [Phase 4]
Open-label, long-term Phase 4 study assessing immunogenicity ofLinaclotide (LINZESS) in adults with irritable bowel syndrome with constipati…
-
CLINICAL_TRIALS trial_result · 2019-08-20Clinical Trial Update: The Effect of CSP01 on Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation [NA]
Clinical trial update on CSP01 for chronic idiopathic constipation and irritable bowel syndrome with constipation has completed with results…